Author

K. Akamatsu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Organism:chicken / avian· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

H. Arase· 2 shared J.-i. Kishikawa· 2 shared M. Hirose· 2 shared M. Okada· 2 shared T. Kato· 2 shared Y. Matsuura· 2 shared A. Arakawa· 1 shared A. Hoshino· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. Arase

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintDec 29, 2022

An engineered ACE2 decoy broadly neutralizes Omicron subvariants and shows therapeutic effect in SARS-CoV-2-infected cynomolgus macaques

E. Urano, Y. Itoh, T. Suzuki…·T. Okamoto

This paper shows an engineered ACE2 decoy neutralizes Omicron subvariants and is effective in treating SARS-CoV-2 infection in macaques.

DOI 10.1101/2022.12.29.522275

chicken / avianexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintAug 22, 2021

The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines

Y. Liu, N. Arase, J.-i. Kishikawa…·H. Arase

The paper shows the Delta variant can escape NTD antibodies and gain infectivity when specific RBD mutations are present, suggesting the need for updated vaccines.

DOI 10.1101/2021.08.22.457114

humanbulk RNA-seq

𝕏 PostBluesky